nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.122	0.248	CbGbCtD
Maraviroc—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0924	0.188	CbGbCtD
Maraviroc—CYP3A4—Betamethasone—ankylosing spondylitis	0.0793	0.161	CbGbCtD
Maraviroc—CYP3A4—Prednisolone—ankylosing spondylitis	0.0782	0.159	CbGbCtD
Maraviroc—CYP3A4—Prednisone—ankylosing spondylitis	0.0739	0.15	CbGbCtD
Maraviroc—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0461	0.0938	CbGbCtD
Maraviroc—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000724	0.00143	CcSEcCtD
Maraviroc—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000719	0.00142	CcSEcCtD
Maraviroc—Neutropenia—Prednisone—ankylosing spondylitis	0.000717	0.00141	CcSEcCtD
Maraviroc—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000703	0.00138	CcSEcCtD
Maraviroc—Hallucination—Betamethasone—ankylosing spondylitis	0.000701	0.00138	CcSEcCtD
Maraviroc—Hallucination—Dexamethasone—ankylosing spondylitis	0.000701	0.00138	CcSEcCtD
Maraviroc—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000698	0.00137	CcSEcCtD
Maraviroc—Depression—Prednisone—ankylosing spondylitis	0.000682	0.00134	CcSEcCtD
Maraviroc—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000679	0.00134	CcSEcCtD
Maraviroc—Erythema—Triamcinolone—ankylosing spondylitis	0.000676	0.00133	CcSEcCtD
Maraviroc—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000675	0.00133	CcSEcCtD
Maraviroc—Erythema—Methylprednisolone—ankylosing spondylitis	0.000675	0.00133	CcSEcCtD
Maraviroc—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000674	0.00133	CcSEcCtD
Maraviroc—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00067	0.00132	CcSEcCtD
Maraviroc—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00067	0.00132	CcSEcCtD
Maraviroc—Breast disorder—Methotrexate—ankylosing spondylitis	0.00067	0.00132	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000668	0.00131	CcSEcCtD
Maraviroc—Syncope—Prednisolone—ankylosing spondylitis	0.000659	0.0013	CcSEcCtD
Maraviroc—Eye disorder—Betamethasone—ankylosing spondylitis	0.000659	0.0013	CcSEcCtD
Maraviroc—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000659	0.0013	CcSEcCtD
Maraviroc—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000646	0.00127	CcSEcCtD
Maraviroc—Angiopathy—Betamethasone—ankylosing spondylitis	0.000639	0.00126	CcSEcCtD
Maraviroc—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000639	0.00126	CcSEcCtD
Maraviroc—Convulsion—Prednisolone—ankylosing spondylitis	0.000637	0.00125	CcSEcCtD
Maraviroc—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000634	0.00125	CcSEcCtD
Maraviroc—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000628	0.00124	CcSEcCtD
Maraviroc—Alopecia—Betamethasone—ankylosing spondylitis	0.000623	0.00123	CcSEcCtD
Maraviroc—Alopecia—Dexamethasone—ankylosing spondylitis	0.000623	0.00123	CcSEcCtD
Maraviroc—Discomfort—Prednisolone—ankylosing spondylitis	0.000618	0.00122	CcSEcCtD
Maraviroc—Erythema—Betamethasone—ankylosing spondylitis	0.000613	0.00121	CcSEcCtD
Maraviroc—Erythema—Dexamethasone—ankylosing spondylitis	0.000613	0.00121	CcSEcCtD
Maraviroc—Hallucination—Prednisone—ankylosing spondylitis	0.000611	0.0012	CcSEcCtD
Maraviroc—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000608	0.0012	CcSEcCtD
Maraviroc—Syncope—Triamcinolone—ankylosing spondylitis	0.000606	0.00119	CcSEcCtD
Maraviroc—Syncope—Methylprednisolone—ankylosing spondylitis	0.000605	0.00119	CcSEcCtD
Maraviroc—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000603	0.00119	CcSEcCtD
Maraviroc—Oedema—Prednisolone—ankylosing spondylitis	0.0006	0.00118	CcSEcCtD
Maraviroc—Neutropenia—Methotrexate—ankylosing spondylitis	0.000599	0.00118	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000596	0.00117	CcSEcCtD
Maraviroc—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000594	0.00117	CcSEcCtD
Maraviroc—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000593	0.00117	CcSEcCtD
Maraviroc—Shock—Prednisolone—ankylosing spondylitis	0.00059	0.00116	CcSEcCtD
Maraviroc—Cough—Triamcinolone—ankylosing spondylitis	0.00059	0.00116	CcSEcCtD
Maraviroc—Convulsion—Triamcinolone—ankylosing spondylitis	0.000586	0.00115	CcSEcCtD
Maraviroc—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000584	0.00115	CcSEcCtD
Maraviroc—Myalgia—Triamcinolone—ankylosing spondylitis	0.000576	0.00113	CcSEcCtD
Maraviroc—Pneumonia—Methotrexate—ankylosing spondylitis	0.000575	0.00113	CcSEcCtD
Maraviroc—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000574	0.00113	CcSEcCtD
Maraviroc—Eye disorder—Prednisone—ankylosing spondylitis	0.000573	0.00113	CcSEcCtD
Maraviroc—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000572	0.00113	CcSEcCtD
Maraviroc—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000571	0.00112	CcSEcCtD
Maraviroc—Infestation—Methotrexate—ankylosing spondylitis	0.000571	0.00112	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00057	0.00112	CcSEcCtD
Maraviroc—Depression—Methotrexate—ankylosing spondylitis	0.00057	0.00112	CcSEcCtD
Maraviroc—Discomfort—Triamcinolone—ankylosing spondylitis	0.000569	0.00112	CcSEcCtD
Maraviroc—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000567	0.00112	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000566	0.00111	CcSEcCtD
Maraviroc—Renal failure—Methotrexate—ankylosing spondylitis	0.000562	0.00111	CcSEcCtD
Maraviroc—Stomatitis—Methotrexate—ankylosing spondylitis	0.000557	0.0011	CcSEcCtD
Maraviroc—Angiopathy—Prednisone—ankylosing spondylitis	0.000557	0.0011	CcSEcCtD
Maraviroc—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000555	0.00109	CcSEcCtD
Maraviroc—Oedema—Triamcinolone—ankylosing spondylitis	0.000552	0.00109	CcSEcCtD
Maraviroc—Syncope—Betamethasone—ankylosing spondylitis	0.00055	0.00108	CcSEcCtD
Maraviroc—Syncope—Dexamethasone—ankylosing spondylitis	0.00055	0.00108	CcSEcCtD
Maraviroc—Infection—Triamcinolone—ankylosing spondylitis	0.000548	0.00108	CcSEcCtD
Maraviroc—Infection—Methylprednisolone—ankylosing spondylitis	0.000547	0.00108	CcSEcCtD
Maraviroc—Shock—Triamcinolone—ankylosing spondylitis	0.000543	0.00107	CcSEcCtD
Maraviroc—Insomnia—Prednisolone—ankylosing spondylitis	0.000543	0.00107	CcSEcCtD
Maraviroc—Alopecia—Prednisone—ankylosing spondylitis	0.000542	0.00107	CcSEcCtD
Maraviroc—Shock—Methylprednisolone—ankylosing spondylitis	0.000542	0.00107	CcSEcCtD
Maraviroc—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00054	0.00106	CcSEcCtD
Maraviroc—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00054	0.00106	CcSEcCtD
Maraviroc—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000539	0.00106	CcSEcCtD
Maraviroc—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000539	0.00106	CcSEcCtD
Maraviroc—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000539	0.00106	CcSEcCtD
Maraviroc—Mental disorder—Prednisone—ankylosing spondylitis	0.000538	0.00106	CcSEcCtD
Maraviroc—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000535	0.00105	CcSEcCtD
Maraviroc—Erythema—Prednisone—ankylosing spondylitis	0.000534	0.00105	CcSEcCtD
Maraviroc—Malnutrition—Prednisone—ankylosing spondylitis	0.000534	0.00105	CcSEcCtD
Maraviroc—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000533	0.00105	CcSEcCtD
Maraviroc—Convulsion—Betamethasone—ankylosing spondylitis	0.000531	0.00105	CcSEcCtD
Maraviroc—Convulsion—Dexamethasone—ankylosing spondylitis	0.000531	0.00105	CcSEcCtD
Maraviroc—Myalgia—Betamethasone—ankylosing spondylitis	0.000522	0.00103	CcSEcCtD
Maraviroc—Myalgia—Dexamethasone—ankylosing spondylitis	0.000522	0.00103	CcSEcCtD
Maraviroc—Anxiety—Betamethasone—ankylosing spondylitis	0.00052	0.00102	CcSEcCtD
Maraviroc—Anxiety—Dexamethasone—ankylosing spondylitis	0.00052	0.00102	CcSEcCtD
Maraviroc—Discomfort—Betamethasone—ankylosing spondylitis	0.000516	0.00102	CcSEcCtD
Maraviroc—Discomfort—Dexamethasone—ankylosing spondylitis	0.000516	0.00102	CcSEcCtD
Maraviroc—Pain—Prednisolone—ankylosing spondylitis	0.000513	0.00101	CcSEcCtD
Maraviroc—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000509	0.001	CcSEcCtD
Maraviroc—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000506	0.000997	CcSEcCtD
Maraviroc—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000503	0.000989	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000503	0.000989	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000502	0.000987	CcSEcCtD
Maraviroc—Oedema—Dexamethasone—ankylosing spondylitis	0.000501	0.000985	CcSEcCtD
Maraviroc—Oedema—Betamethasone—ankylosing spondylitis	0.000501	0.000985	CcSEcCtD
Maraviroc—Insomnia—Triamcinolone—ankylosing spondylitis	0.000499	0.000982	CcSEcCtD
Maraviroc—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000498	0.00098	CcSEcCtD
Maraviroc—Infection—Dexamethasone—ankylosing spondylitis	0.000497	0.000979	CcSEcCtD
Maraviroc—Infection—Betamethasone—ankylosing spondylitis	0.000497	0.000979	CcSEcCtD
Maraviroc—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000495	0.000975	CcSEcCtD
Maraviroc—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000494	0.000973	CcSEcCtD
Maraviroc—Anaemia—Prednisone—ankylosing spondylitis	0.000494	0.000972	CcSEcCtD
Maraviroc—Shock—Betamethasone—ankylosing spondylitis	0.000493	0.000969	CcSEcCtD
Maraviroc—Shock—Dexamethasone—ankylosing spondylitis	0.000493	0.000969	CcSEcCtD
Maraviroc—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000491	0.000966	CcSEcCtD
Maraviroc—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000491	0.000966	CcSEcCtD
Maraviroc—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000485	0.000954	CcSEcCtD
Maraviroc—Eye disorder—Methotrexate—ankylosing spondylitis	0.000479	0.000943	CcSEcCtD
Maraviroc—Syncope—Prednisone—ankylosing spondylitis	0.000479	0.000943	CcSEcCtD
Maraviroc—Anorexia—Dexamethasone—ankylosing spondylitis	0.000477	0.000939	CcSEcCtD
Maraviroc—Anorexia—Betamethasone—ankylosing spondylitis	0.000477	0.000939	CcSEcCtD
Maraviroc—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000476	0.000937	CcSEcCtD
Maraviroc—Fatigue—Triamcinolone—ankylosing spondylitis	0.000476	0.000936	CcSEcCtD
Maraviroc—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000475	0.000934	CcSEcCtD
Maraviroc—Pain—Triamcinolone—ankylosing spondylitis	0.000472	0.000928	CcSEcCtD
Maraviroc—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00047	0.000924	CcSEcCtD
Maraviroc—Angiopathy—Methotrexate—ankylosing spondylitis	0.000465	0.000916	CcSEcCtD
Maraviroc—Convulsion—Prednisone—ankylosing spondylitis	0.000463	0.000911	CcSEcCtD
Maraviroc—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000462	0.00091	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000456	0.000898	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000456	0.000898	CcSEcCtD
Maraviroc—Myalgia—Prednisone—ankylosing spondylitis	0.000455	0.000895	CcSEcCtD
Maraviroc—Anxiety—Prednisone—ankylosing spondylitis	0.000453	0.000892	CcSEcCtD
Maraviroc—Alopecia—Methotrexate—ankylosing spondylitis	0.000453	0.000892	CcSEcCtD
Maraviroc—Insomnia—Betamethasone—ankylosing spondylitis	0.000453	0.000891	CcSEcCtD
Maraviroc—Insomnia—Dexamethasone—ankylosing spondylitis	0.000453	0.000891	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000452	0.000889	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00045	0.000886	CcSEcCtD
Maraviroc—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00045	0.000885	CcSEcCtD
Maraviroc—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00045	0.000885	CcSEcCtD
Maraviroc—Discomfort—Prednisone—ankylosing spondylitis	0.000449	0.000884	CcSEcCtD
Maraviroc—Mental disorder—Methotrexate—ankylosing spondylitis	0.000449	0.000884	CcSEcCtD
Maraviroc—Erythema—Methotrexate—ankylosing spondylitis	0.000446	0.000879	CcSEcCtD
Maraviroc—Malnutrition—Methotrexate—ankylosing spondylitis	0.000446	0.000879	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000442	0.00087	CcSEcCtD
Maraviroc—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000436	0.000858	CcSEcCtD
Maraviroc—Oedema—Prednisone—ankylosing spondylitis	0.000436	0.000858	CcSEcCtD
Maraviroc—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000435	0.000856	CcSEcCtD
Maraviroc—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000435	0.000856	CcSEcCtD
Maraviroc—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000435	0.000856	CcSEcCtD
Maraviroc—Infection—Prednisone—ankylosing spondylitis	0.000433	0.000852	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000432	0.000851	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000432	0.000851	CcSEcCtD
Maraviroc—Fatigue—Dexamethasone—ankylosing spondylitis	0.000432	0.000849	CcSEcCtD
Maraviroc—Fatigue—Betamethasone—ankylosing spondylitis	0.000432	0.000849	CcSEcCtD
Maraviroc—Shock—Prednisone—ankylosing spondylitis	0.000429	0.000844	CcSEcCtD
Maraviroc—Pain—Betamethasone—ankylosing spondylitis	0.000428	0.000842	CcSEcCtD
Maraviroc—Pain—Dexamethasone—ankylosing spondylitis	0.000428	0.000842	CcSEcCtD
Maraviroc—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000428	0.000841	CcSEcCtD
Maraviroc—Skin disorder—Prednisone—ankylosing spondylitis	0.000423	0.000833	CcSEcCtD
Maraviroc—Anorexia—Prednisone—ankylosing spondylitis	0.000416	0.000818	CcSEcCtD
Maraviroc—Anaemia—Methotrexate—ankylosing spondylitis	0.000413	0.000812	CcSEcCtD
Maraviroc—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000409	0.000806	CcSEcCtD
Maraviroc—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000409	0.000806	CcSEcCtD
Maraviroc—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000407	0.0008	CcSEcCtD
Maraviroc—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000406	0.000798	CcSEcCtD
Maraviroc—Leukopenia—Methotrexate—ankylosing spondylitis	0.0004	0.000786	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000397	0.000782	CcSEcCtD
Maraviroc—Dizziness—Prednisolone—ankylosing spondylitis	0.000397	0.000781	CcSEcCtD
Maraviroc—Asthenia—Triamcinolone—ankylosing spondylitis	0.000396	0.000779	CcSEcCtD
Maraviroc—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000396	0.000779	CcSEcCtD
Maraviroc—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000396	0.000779	CcSEcCtD
Maraviroc—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000396	0.000779	CcSEcCtD
Maraviroc—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000396	0.000779	CcSEcCtD
Maraviroc—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000395	0.000777	CcSEcCtD
Maraviroc—Insomnia—Prednisone—ankylosing spondylitis	0.000394	0.000776	CcSEcCtD
Maraviroc—Paraesthesia—Prednisone—ankylosing spondylitis	0.000391	0.00077	CcSEcCtD
Maraviroc—Pruritus—Triamcinolone—ankylosing spondylitis	0.00039	0.000768	CcSEcCtD
Maraviroc—Cough—Methotrexate—ankylosing spondylitis	0.00039	0.000767	CcSEcCtD
Maraviroc—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000389	0.000766	CcSEcCtD
Maraviroc—Convulsion—Methotrexate—ankylosing spondylitis	0.000387	0.000761	CcSEcCtD
Maraviroc—Myalgia—Methotrexate—ankylosing spondylitis	0.00038	0.000748	CcSEcCtD
Maraviroc—Decreased appetite—Prednisone—ankylosing spondylitis	0.000379	0.000746	CcSEcCtD
Maraviroc—Rash—Prednisolone—ankylosing spondylitis	0.000378	0.000744	CcSEcCtD
Maraviroc—Dermatitis—Prednisolone—ankylosing spondylitis	0.000378	0.000744	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000377	0.000743	CcSEcCtD
Maraviroc—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000377	0.000741	CcSEcCtD
Maraviroc—Fatigue—Prednisone—ankylosing spondylitis	0.000376	0.00074	CcSEcCtD
Maraviroc—Headache—Prednisolone—ankylosing spondylitis	0.000376	0.00074	CcSEcCtD
Maraviroc—Discomfort—Methotrexate—ankylosing spondylitis	0.000376	0.000739	CcSEcCtD
Maraviroc—Constipation—Prednisone—ankylosing spondylitis	0.000373	0.000734	CcSEcCtD
Maraviroc—Dizziness—Triamcinolone—ankylosing spondylitis	0.000365	0.000718	CcSEcCtD
Maraviroc—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000364	0.000716	CcSEcCtD
Maraviroc—Infection—Methotrexate—ankylosing spondylitis	0.000362	0.000712	CcSEcCtD
Maraviroc—Asthenia—Dexamethasone—ankylosing spondylitis	0.000359	0.000707	CcSEcCtD
Maraviroc—Asthenia—Betamethasone—ankylosing spondylitis	0.000359	0.000707	CcSEcCtD
Maraviroc—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000357	0.000703	CcSEcCtD
Maraviroc—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000357	0.000702	CcSEcCtD
Maraviroc—Nausea—Prednisolone—ankylosing spondylitis	0.000356	0.000701	CcSEcCtD
Maraviroc—Pruritus—Dexamethasone—ankylosing spondylitis	0.000354	0.000697	CcSEcCtD
Maraviroc—Pruritus—Betamethasone—ankylosing spondylitis	0.000354	0.000697	CcSEcCtD
Maraviroc—Skin disorder—Methotrexate—ankylosing spondylitis	0.000354	0.000696	CcSEcCtD
Maraviroc—Vomiting—Triamcinolone—ankylosing spondylitis	0.000351	0.00069	CcSEcCtD
Maraviroc—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00035	0.000689	CcSEcCtD
Maraviroc—Rash—Triamcinolone—ankylosing spondylitis	0.000348	0.000685	CcSEcCtD
Maraviroc—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000348	0.000684	CcSEcCtD
Maraviroc—Anorexia—Methotrexate—ankylosing spondylitis	0.000347	0.000683	CcSEcCtD
Maraviroc—Rash—Methylprednisolone—ankylosing spondylitis	0.000347	0.000683	CcSEcCtD
Maraviroc—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000347	0.000682	CcSEcCtD
Maraviroc—Headache—Triamcinolone—ankylosing spondylitis	0.000346	0.00068	CcSEcCtD
Maraviroc—Headache—Methylprednisolone—ankylosing spondylitis	0.000345	0.000679	CcSEcCtD
Maraviroc—Abdominal pain—Prednisone—ankylosing spondylitis	0.000345	0.000678	CcSEcCtD
Maraviroc—Body temperature increased—Prednisone—ankylosing spondylitis	0.000345	0.000678	CcSEcCtD
Maraviroc—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000343	0.000674	CcSEcCtD
Maraviroc—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000343	0.000674	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000332	0.000653	CcSEcCtD
Maraviroc—Dizziness—Dexamethasone—ankylosing spondylitis	0.000331	0.000651	CcSEcCtD
Maraviroc—Dizziness—Betamethasone—ankylosing spondylitis	0.000331	0.000651	CcSEcCtD
Maraviroc—Insomnia—Methotrexate—ankylosing spondylitis	0.00033	0.000649	CcSEcCtD
Maraviroc—Nausea—Triamcinolone—ankylosing spondylitis	0.000328	0.000645	CcSEcCtD
Maraviroc—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000327	0.000644	CcSEcCtD
Maraviroc—Nausea—Methylprednisolone—ankylosing spondylitis	0.000327	0.000644	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000321	0.000632	CcSEcCtD
Maraviroc—Vomiting—Betamethasone—ankylosing spondylitis	0.000318	0.000626	CcSEcCtD
Maraviroc—Vomiting—Dexamethasone—ankylosing spondylitis	0.000318	0.000626	CcSEcCtD
Maraviroc—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000317	0.000623	CcSEcCtD
Maraviroc—Rash—Betamethasone—ankylosing spondylitis	0.000316	0.000621	CcSEcCtD
Maraviroc—Rash—Dexamethasone—ankylosing spondylitis	0.000316	0.000621	CcSEcCtD
Maraviroc—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000315	0.000621	CcSEcCtD
Maraviroc—Dermatitis—Betamethasone—ankylosing spondylitis	0.000315	0.000621	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000315	0.000619	CcSEcCtD
Maraviroc—Fatigue—Methotrexate—ankylosing spondylitis	0.000314	0.000618	CcSEcCtD
Maraviroc—Headache—Betamethasone—ankylosing spondylitis	0.000314	0.000617	CcSEcCtD
Maraviroc—Headache—Dexamethasone—ankylosing spondylitis	0.000314	0.000617	CcSEcCtD
Maraviroc—Asthenia—Prednisone—ankylosing spondylitis	0.000313	0.000616	CcSEcCtD
Maraviroc—Pain—Methotrexate—ankylosing spondylitis	0.000312	0.000613	CcSEcCtD
Maraviroc—Pruritus—Prednisone—ankylosing spondylitis	0.000308	0.000607	CcSEcCtD
Maraviroc—Diarrhoea—Prednisone—ankylosing spondylitis	0.000298	0.000587	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000298	0.000586	CcSEcCtD
Maraviroc—Nausea—Dexamethasone—ankylosing spondylitis	0.000297	0.000585	CcSEcCtD
Maraviroc—Nausea—Betamethasone—ankylosing spondylitis	0.000297	0.000585	CcSEcCtD
Maraviroc—Dizziness—Prednisone—ankylosing spondylitis	0.000288	0.000567	CcSEcCtD
Maraviroc—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000288	0.000567	CcSEcCtD
Maraviroc—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000288	0.000567	CcSEcCtD
Maraviroc—Vomiting—Prednisone—ankylosing spondylitis	0.000277	0.000546	CcSEcCtD
Maraviroc—Rash—Prednisone—ankylosing spondylitis	0.000275	0.000541	CcSEcCtD
Maraviroc—Dermatitis—Prednisone—ankylosing spondylitis	0.000275	0.00054	CcSEcCtD
Maraviroc—Headache—Prednisone—ankylosing spondylitis	0.000273	0.000537	CcSEcCtD
Maraviroc—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000268	0.000528	CcSEcCtD
Maraviroc—Asthenia—Methotrexate—ankylosing spondylitis	0.000261	0.000514	CcSEcCtD
Maraviroc—Nausea—Prednisone—ankylosing spondylitis	0.000259	0.00051	CcSEcCtD
Maraviroc—Pruritus—Methotrexate—ankylosing spondylitis	0.000258	0.000507	CcSEcCtD
Maraviroc—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000249	0.000491	CcSEcCtD
Maraviroc—Dizziness—Methotrexate—ankylosing spondylitis	0.000241	0.000474	CcSEcCtD
Maraviroc—Vomiting—Methotrexate—ankylosing spondylitis	0.000232	0.000456	CcSEcCtD
Maraviroc—Rash—Methotrexate—ankylosing spondylitis	0.00023	0.000452	CcSEcCtD
Maraviroc—Dermatitis—Methotrexate—ankylosing spondylitis	0.00023	0.000452	CcSEcCtD
Maraviroc—Headache—Methotrexate—ankylosing spondylitis	0.000228	0.000449	CcSEcCtD
Maraviroc—Nausea—Methotrexate—ankylosing spondylitis	0.000216	0.000426	CcSEcCtD
